(Q41323567)

29 September 2017

title

Plasma lipids and acyltransferase activities in experimental nephrotic syndrome (English)

1 reference

29 September 2017

Sestak TL

1

1 reference

29 September 2017

Alavi N

series ordinal

2

1 reference

29 September 2017

Subbaiah PV

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

29 September 2017

1 reference

29 September 2017

volume

36

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

240-248

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1989.186

29 September 2017

exact match

0 references

cites work

Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Lipogenesis in aminonucleoside-induced nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Ischaemic heart-disease as a complication of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Cardiovascular Disease and the Nephrotic Syndrome: the other Side of the Coin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Selective Phospholipid Adsorption and Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Pathophysiology of the kidney in rats with Heymann nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Albumin standards and the measurement of serum albumin with bromcresol green

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Lysolecithin acyltransferase of human plasma: assay and characterization of enzyme activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Determination of Lecithin: Cholesterol Acyltransfer in Human Blood Plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Selectivity and contribution of lecithin: cholesterol acyltransferase to plasma cholesterol ester formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

The mechanism of hyperlipidaemia in nephrotic syndrome--role of low albumin and the LCAT reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

The Nephrotic Syndrome and Ischaemic Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.186

7 January 2021

Identifiers

DOI

10.1038/KI.1989.186

1 reference

Dimensions Publication ID

29 September 2017

1001491705

0 references

1 reference